Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Economic"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
20
of
261
Search:
'"Economic"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cobicistat /
economics
...
”
Read Now
2
Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiviral Agents /
economics
...
”
Read Now
3
Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiviral Agents /
economics
...
”
Read Now
4
Antibiotic impregnated cement for primary hip or knee arthroplasty : a review of the clinical and cost-effectiveness
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Arthroplasty, Replacement, Hip /
economics
...
”
Read Now
5
Costs of contact tracing activities aimed at reducing the transmission of measles in Canada
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Contact Tracing /
economics
...
”
Read Now
6
Non-invasive prenatal testing : a review of the cost effectiveness and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-Benefit Analysis /
economics
...
”
Read Now
7
Costs of contact tracing activities aimed at reducing the transmission of measles in Canada
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Contact Tracing /
economics
...
”
Read Now
8
Pharmacoeconomic review report: Apomorphine (Movapo) (Paladin Labs, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Dopamine Agonists /
economics
...
”
Read Now
9
Denosumab versus zoledronic acid for adults with osteoporosis : a review of cost-effectiveness
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Denosumab /
economics
...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.
Published 2018
CADTH
Subjects:
“
...Antiviral Agents /
economics
...
”
Read Now
11
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Omalizumab /
economics
...
”
Read Now
12
Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Thiophenes /
economics
...
”
Read Now
13
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Omalizumab /
economics
...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...
Published 2018
CADTH
Subjects:
“
...Immunologic Factors /
economics
...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Ivabradine /
economics
...
”
Read Now
16
CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Insurance, Pharmaceutical Services /
economics
...
”
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Ivabradine /
economics
...
”
Read Now
18
Pharmacoeconomic review report: Tiotropium bromide monohydrate (Spiriva respimat) for inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tiotropium Bromide /
economics
...
”
Read Now
19
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal, Humanized /
economics
...
”
Read Now
20
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal, Humanized /
economics
...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
330 - Economics
261
610 - Medicine & health
89
140 - Specific philosophical schools
21
700 - The arts; fine & decorative arts
18
580 - Plants (Botany)
3
600 - Technology
2
more ...
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
800 - Literature & rhetoric
1
see all ...
less ...
Language
English
261
Collection
National Center for Biotechnology Information
261
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
58
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
29
Adcock, Lorna
7
Ho, Chuong
7
Ford, Caitlyn
6
more ...
Grobelna, Aleksandra
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
McCormack, Suzanne
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Frey, Nina
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Perras, Christine
2
Poitras, Veronica
2
Spry, Carolyn
2
Visintini, Sarah
2
Wells, George A.
2
Adams, Alison
1
Assasi, Nazila
1
Chiu, Stephanie
1
Clark, Michelle
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Klarenbach, Scott
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Lee, Karen M.
1
Marchand, Dave K.
1
McIntosh, Brendan
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
Thompson, Wade
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22Economic%22&type=Subject
Send by Email
×
Loading...